These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy. von Stuelpnagel C, Holthausen H, Kluger G. Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601 [Abstract] [Full Text] [Related]
8. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF. Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [Abstract] [Full Text] [Related]
9. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Specchio LM, Gambardella A, Giallonardo AT, Michelucci R, Specchio N, Boero G, La Neve A. Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521 [Abstract] [Full Text] [Related]
10. Levetiracetam monotherapy for late poststroke seizures in the elderly. Kutlu G, Gomceli YB, Unal Y, Inan LE. Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085 [Abstract] [Full Text] [Related]
11. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group. Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [Abstract] [Full Text] [Related]
12. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, Nardello R, Habetswallner F, Licciardi F, Operto FF, Pascotto A. Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165 [Abstract] [Full Text] [Related]